The divestiture package included some Amedisys home health centers and some locations owned by Optum. In the complaint, the Justice Department said that VitalCaring is unlikely to replace the ...
Oppenheimer analyst Michael Wiederhorn is updating its Amedisys (AMED) model following the Q4 earnings release. Amedisys is currently in the ...
Dealbreaker on MSN3mon
Why The DOJ’s Lawsuit Against The UGH-Amedisys Merger May Not Go AnywhereBy acquiring Amedisys, UHG would grow its home health and hospice footprint to five more states, as well as receive 500 ...
Amedisys has a twelve month low of $82.15 and a twelve month high of $98.95. Get Amedisys alerts: Amedisys (NASDAQ:AMED – Get Free Report) last announced its quarterly earnings results on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback